A carregar...

“Optimization of Phase-Change Contrast Agents for Targeting MDA-MB-231 Breast Cancer Cells”

Breast cancer remains a leading cause of death for women throughout the world. Recent advances in medical imaging technologies and tumor targeting agents signify vast potential for progress toward improved management of this global problem. Phase-change contrast agents (PCCAs) are a dynamic imaging...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ultrasound Med Biol
Main Authors: Hadinger, Kyle P., Marshalek, Joseph P., Sheeran, Paul S., Dayton, Paul A., Matsunaga, Terry O.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6215505/
https://ncbi.nlm.nih.gov/pubmed/30228045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ultrasmedbio.2018.08.003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!